Achieve Life Sciences (ACHV) Shares Issued (2017 - 2025)

Achieve Life Sciences (ACHV) has 17 years of Shares Issued data on file, last reported at $5.0 million in Q1 2026.

• Quarterly Shares Issued rose 119.55% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 119.55% YoY) and the FY2025 annual result came in at $2.7 million, up 27.61% from the prior year.
• Shares Issued grew to $5.0 million in Q1 2026, from $2.7 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $5.0 million in Q1 2026 to a low of $789940.0 in Q1 2022.
• A 5-year average of $1.8 million and a median of $1.9 million in 2024 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2025 — Shares Issued climbed 9.63% — and 2026, when it jumped 119.55%.
• Tracing ACHV's Shares Issued over 5 years: stood at $822515.0 in 2022, then jumped by 77.75% to $1.5 million in 2023, then soared by 46.34% to $2.1 million in 2024, then climbed by 27.61% to $2.7 million in 2025, then soared by 82.06% to $5.0 million in 2026.
• The last three Shares Issued figures came in at $5.0 million (Q1 2026), $2.7 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.